Shedding Light on FIRE Syndrome: An Overview of a Novel Condition in Eosinophilic Esophagitis
Source abstract
Abstract
Food-Induced Immediate Response of the Esophagus (FIRE) is a newly described syndrome observed in eosinophilic esophagitis (EoE) patients. It is defined by an immediate hypersensitivity reaction of the esophagus that occurs when specific foods and beverages interface with esophageal mucosa. The available data regarding this topic is scarce. Therefore, we aimed to review relevant publications in order to better characterize the main aspects of this syndrome and hypothesize about potential mechanisms underlying FIRE syndrome and possible future therapeutic approaches. We searched PubMed, Embase, and Web of Science databases for relevant articles published before February 1st, 2025. The results were narrowed down to four articles describing a total of 105 cases of FIRE syndrome. These patients had a distinct clinical presentation, characterized by retrosternal discomfort or pain, differentiating it from solid food dysphagia or pollen-food allergy syndrome (PFAS). Currently, diagnosis is based on clinical presentation, with no diagnostic tests or biomarkers available. Emerging evidence suggests that IgE-mediated hypersensitivity, mast cells, and neuroimmune interactions may play a central role in the pathogenesis of FIRE syndrome. The therapeutic approaches remain speculative, with trigger avoidance being the main option. This article brings to the forefront the need for continued research to address current knowledge gaps regarding FIRE syndrome, which is important for optimizing patient management.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Eosinophilic Esophagitis · Eosinophilic Disorders and Syndromes
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Allergology Department, “Carol Davila” University of Medicine and Pharmacy, 050474 Bucharest, Romania
Department of Allergology and Clinical Immunology, “Carol Davila” Nephrology Clinical Hospital, 010731 Bucharest, Romania
Pediatrics Department, “Carol Davila” University of Medicine and Pharmacy, 050474 Bucharest, Romania
Department of Allergology and Clinical Immunology, “Marie S. Curie” Emergency Children’s Clinical Hospital, 077120 Bucharest, Romania
Funding
University of Medicine and Pharmacy Carol Davila
References (100+)
Show source-provided references
1. Eosinophilic Esophagitis Is a Late Manifestation of the Allergic March10.1016/j.jaip.2018.05.010 ↗
2. Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE Conference10.1053/j.gastro.2018.07.009 ↗
3. Are Endoscopic Changes Predictive of Histologic Esophagitis in Children?10.1016/S0022-3476(83)80347-3 ↗
4. Esophageal Eosinophilia with Dysphagia: A Distinct Clinicopathologic Syndrome10.1007/BF01296781 ↗
5. Update on Basic and Clinical Aspects of Eosinophilic Oesophagitis10.1136/gutjnl-2013-306414 ↗
6. Systematic Review with Meta-analysis: The Growing Incidence and Prevalence of Eosinophilic Oesophagitis in Children and Adults in Population-based Studies10.1111/apt.15231 ↗
7. Epidemiology and Natural History of Atopic Diseases10.3402/ecrj.v2.24642 ↗
8. Eosinophilic Esophagitis: A Review10.1001/jama.2021.14920 ↗
9. Pediatric Eosinophilic Esophagitis: A Review for the Clinician10.1186/s13052-021-01178-2 ↗
10. Systematic Review of Feeding Difficulties in Children with Eosinophilic Esophagitis: An EAACI Task Force Report10.1111/pai.70087 ↗
11. Eosinophilic Esophagitis: Update on Management and Controversies10.1136/bmj.j4482 ↗
12. Behavioral Issues and Quality of Life in Children with Eosinophilic Esophagitis10.23736/S0026-4946.20.05913-7 ↗
13. Delay in Diagnosis of Eosinophilic Esophagitis Increases Risk for Stricture Formation in a Time-Dependent Manner10.1053/j.gastro.2013.08.015 ↗
14. Diagnostic Delay in Patients with Eosinophilic Esophagitis Has Not Changed Since the First Description 30 Years Ago: Diagnostic Delay in Eosinophilic Esophagitis10.14309/ajg.0000000000001950 ↗
15. Disease Activity in Eosinophilic Esophagitis Is Associated with Impaired Esophageal Barrier Integrity10.1152/ajpgi.00058.2017 ↗
16. Food-induced Immediate Response of the Esophagus—A Newly Identified Syndrome in Patients with Eosinophilic Esophagitis10.1111/all.14495 ↗
17. Features of Food-Induced Immediate Response in the Esophagus (FIRE) in a Series of Adult Patients with Eosinophilic Esophagitis10.1111/all.14886 ↗
18. Food-induced Immediate Response of the Esophagus: A First Report in the Pediatric Age10.1111/all.15088 ↗
19. Food-Induced Immediate Response of the Esophagus in Pediatric Eosinophilic Esophagitis10.1111/all.15881 ↗
20. Allergies and Eosinophilic Esophagitis—Current Updates for the Pediatric Gastroenterologist10.1007/s11894-019-0729-y ↗
21. Comparison of Comorbid Diagnoses in Children with and Without Eosinophilic Esophagitis in a Large Population10.1016/j.anai.2018.08.022 ↗
22. Eosinophilic Esophagitis: Clinical, Endoscopic, Histologic and Therapeutic Differences and Similarities between Children and Adults10.1177/1756284820980860 ↗
23. Update on Pollen-Food Allergy Syndrome10.1080/1744666X.2020.1774366 ↗
24. Eosinophilic Oesophagitis: Recent Advances and Practical Management10.1136/flgastro-2019-101313 ↗
25. A Novel Pediatric Eosinophilic Esophagitis Symptoms and Adaptive Behavior Scale for Different Ages: GaziESAS v2.0. Pediatr
26. Pollen-Food Allergy Syndrome Is a Common Allergic Comorbidity in Adults with Eosinophilic Esophagitis10.1093/dote/dox122 ↗
27. An International Delphi Consensus on the Management of Pollen-Food Allergy Syndrome: A Work Group Report of the AAAAI Adverse Reactions to Foods Committee10.1016/j.jaip.2024.09.037 ↗
28. Triggers for Eosinophilic Esophagitis (EoE): The Intersection of Food Allergy and EoE10.1016/j.jaci.2024.04.010 ↗
29. Identification of Causative Foods in Children with Eosinophilic Esophagitis Treated with an Elimination Diet10.1016/j.jaci.2012.05.021 ↗
30. Allergic Components of Eosinophilic Esophagitis10.1016/j.jaci.2018.05.001 ↗
31. Empiric 6-Food Elimination Diet Induced and Maintained Prolonged Remission in Patients with Adult Eosinophilic Esophagitis: A Prospective Study on the Food Cause of the Disease10.1016/j.jaci.2012.12.664 ↗
32. Esophageal Remodeling Correlates with Eating Behaviors in Pediatric Eosinophilic Esophagitis10.14309/ajg.0000000000002661 ↗
33. Immune System and Microbiome in the Esophagus: Implications for Understanding Inflammatory Diseases10.1111/febs.16103 ↗
34. Characterization of Immune Cell Populations and Acid-Sensing Receptors in the Human Esophagus10.3390/gastroent15030058 ↗
35. The Contribution of Intraepithelial Inflammatory Cells to the Histological Diagnosis of Microscopic Esophagitis10.1007/s10388-015-0501-9 ↗
36. Intrinsic Gastrointestinal Macrophages: Their Phenotype and Role in Gastrointestinal Motility10.1016/j.jcmgh.2016.01.003 ↗
37. Breaking down the Complex Pathophysiology of Eosinophilic Esophagitis10.1016/j.anai.2022.10.026 ↗
38. Immunophenotypic Characterization and Quantification of the Epithelial Inflammatory Infiltrate in Eosinophilic Esophagitis Through Stereology: An Analysis of the Cellular Mechanisms of the Disease and the Immunologic Capacity of the Esophagus10.1097/01.pas.0000213392.49698.8c ↗
39. Local B Cells and IgE Production in the Oesophageal Mucosa in Eosinophilic Oesophagitis10.1136/gut.2009.178020 ↗
40. Critical Role for Adaptive T Cell Immunity in Experimental Eosinophilic Esophagitis in Mice10.1189/jlb.1106653 ↗
41. IgH Chain Class Switch Recombination: Mechanism and Regulation10.4049/jimmunol.1401849 ↗
42. IL-13 Involvement in Eosinophilic Esophagitis: Transcriptome Analysis and Reversibility with Glucocorticoids10.1016/j.jaci.2007.10.024 ↗
43. Mechanism and Regulation of Class Switch Recombination10.1146/annurev.immunol.26.021607.090248 ↗
44. Class Switch Recombination to IgE in the Bronchial Mucosa of Atopic and Nonatopic Patients with Asthma10.1016/j.jaci.2006.09.045 ↗
45. Critical Roles of Activation-Induced Cytidine Deaminase in the Homeostasis of Gut Flora10.1126/science.1077336 ↗
46. Allergen Drives Class Switching to IgE in the Nasal Mucosa in Allergic Rhinitis10.4049/jimmunol.174.8.5024 ↗
47. Abnormal Responses to Local Esophageal Food Allergen Injections in Adult Patients with Eosinophilic Esophagitis10.1053/j.gastro.2017.08.062 ↗
48. Transcriptomic Profiling of the Acute Mucosal Response to Local Food Injections in Adults with Eosinophilic Esophagitis10.1016/j.jaci.2023.10.027 ↗
49. Induction of GITRL Expression in Human Keratinocytes by T H2 Cytokines and TNF-α: Implications for Atopic Dermatitis10.1111/j.1365-2222.2012.03956.x ↗
50. Blockade of GITRL/GITR Signaling Pathway Attenuates House Dust Mite-Induced Allergic Asthma in Mice through Inhibition of MAPKs and NF-κB Signaling10.1016/j.molimm.2021.07.005 ↗
51. Active Eosinophilic Esophagitis Is Characterized by Epithelial Barrier Defects and Eosinophil Extracellular Trap Formation10.1111/all.12570 ↗
52. Mast Cells Disrupt the Function of the Esophageal Epithelial Barrier10.1016/j.mucimm.2023.06.001 ↗
53. Mucosal Impedance Measurements Differentiate Pediatric Patients with Active Versus Inactive Eosinophilic Esophagitis10.1097/MPG.0000000000001943 ↗
54. Effects of Topical Steroids on Tight Junction Proteins and Spongiosis in Esophageal Epithelia of Patients with Eosinophilic Esophagitis10.1016/j.cgh.2014.02.039 ↗
55. Presence of Intraepithelial Food Antigen in Patients with Active Eosinophilic Oesophagitis10.1111/apt.13877 ↗
56. Penetration of the Esophageal Epithelium by Dust Mite Antigen in Patients with Eosinophilic Esophagitis10.1053/j.gastro.2019.02.042 ↗
57. Reithofer, M., and Jahn-Schmid, B. (2017). Allergens with Protease Activity from House Dust Mites. Int. J. Mol. Sci., 18.10.3390/ijms18071368 ↗
58. The Microbiota in Eosinophilic Esophagitis: A Systematic Review10.1111/jgh.15921 ↗
59. Esophageal Microbial Dysbiosis Impairs Mucosal Barrier Integrity via Toll-like Receptor 2 Pathway in Patients with Gastroesophageal Reflux Symptoms10.1186/s12967-024-05878-1 ↗
60. Local Antigen Deposition in Eosinophilic Esophagitis: Implications for Immune Activation10.1053/j.gastro.2019.05.044 ↗
61. Group 2 Innate Lymphocytes (ILC2) Are Enriched in Active Eosinophilic Esophagitis10.1016/j.jaci.2015.05.048 ↗
62. Interleukin 9 Alters Epithelial Barrier and E-cadherin in Eosinophilic Esophagitis10.1097/MPG.0000000000002144 ↗
63. Activated Mucosal Mast Cells Differentiate Eosinophilic (Allergic) Esophagitis from Gastroesophageal Reflux Disease10.1097/MPG.0b013e31802c0d06 ↗
64. Mast Cell Infiltration Is Associated with Persistent Symptoms and Endoscopic Abnormalities Despite Resolution of Eosinophilia in Pediatric Eosinophilic Esophagitis10.14309/ajg.0000000000000474 ↗
65. Mast Cell Effects on Esophageal Smooth Muscle and Their Potential Role in Eosinophilic Esophagitis and Achalasia10.1152/ajpgi.00290.2020 ↗
66. Mast Cell Biology at Molecular Level: A Comprehensive Review10.1007/s12016-019-08769-2 ↗
67. Mast Cell-pain Connection in Eosinophilic Esophagitis10.1111/all.15260 ↗
68. Anti–IL-5 Therapy Reduces Mast Cell and IL-9 Cell Numbers in Pediatric Patients with Eosinophilic Esophagitis10.1016/j.jaci.2013.02.042 ↗
69. The Expression Profile of Acid-Sensing Ion Channel (ASIC) Subunits ASIC1a, ASIC1b, ASIC2a, ASIC2b, and ASIC3 in the Esophageal Vagal Afferent Nerve Subtypes10.1152/ajpgi.00129.2014 ↗
70. Mast Cell-Mediated Long-Lasting Increases in Excitability of Vagal C Fibers in Guinea Pig Esophagus10.1152/ajpgi.00277.2007 ↗
71. Increased Acid Responsiveness in Vagal Sensory Neurons in a Guinea Pig Model of Eosinophilic Esophagitis10.1152/ajpgi.00097.2014 ↗
72. PAR-2 Activation Enhances Weak Acid-Induced ATP Release through TRPV1 and ASIC Sensitization in Human Esophageal Epithelial Cells10.1152/ajpgi.00162.2015 ↗
73. Yu, M., Chang, C., Undem, B.J., and Yu, S. (2021). Capsaicin-Sensitive Vagal Afferent Nerve-Mediated Interoceptive Signals in the Esophagus. Molecules, 26.10.3390/molecules26133929 ↗
74. Acid Hypersensitivity in Patients with Eosinophilic Oesophagitis10.3109/00365520903469931 ↗
75. Upregulation of Acid Sensing Ion Channels Is Associated with Esophageal Hypersensitivity in GERD10.1096/fj.202100606R ↗
76. Eosinophilic Esophagitis—Where Are We Today?10.1016/j.jped.2018.06.012 ↗
77. Elimination Diet in Food Allergy: Friend or Foe?10.1016/j.jped.2023.09.012 ↗
78. Merves, J., Chandramouleeswaran, P.M., Benitez, A.J., Muir, A.B., Lee, A.J., Lim, D.M., Dods, K., Mehta, I., Ruchelli, E.D., and Nakagawa, H. (2015). Altered Esophageal Histamine Receptor Expression in Eosinophilic Esophagitis (EoE): Implications on Disease Pathogenesis. PLoS ONE, 10.10.1371/journal.pone.0114831 ↗
79. Joint ESPGHAN/NASPGHAN Guidelines on Childhood Eosinophilic Gastrointestinal Disorders Beyond Eosinophilic Esophagitis10.1097/MPG.0000000000003877 ↗
80. Systemic Mastocytosis: Current Concepts and Treatment Advances
81. Sinniah, A., Yazid, S., and Flower, R.J. (2017). The Anti-Allergic Cromones: Past, Present, and Future. Front. Pharmacol., 8.10.3389/fphar.2017.00827 ↗
82. A Randomized, Double-Blinded, Placebo-Controlled Study of the Use of Viscous Oral Cromolyn Sodium for the Treatment of Eosinophilic Esophagitis10.1016/j.anai.2018.03.006 ↗
83. Disodium Cromoglycate Treatment Reduces TH2 Immune Response and Immunohistopathological Features in a Murine Model of Eosinophilic Esophagitis10.1016/j.intimp.2020.106422 ↗
84. Oral Disodium Cromoglycate and Ketotifen for a Patient with Eosinophilic Gastroenteritis, Food Allergy and Protein-Losing Enteropathy
85. Eosinophilic Oesophagitis: A Novel Treatment Using Montelukast10.1136/gut.52.2.181 ↗
86. Montelukast Does Not Maintain Symptom Remission After Topical Steroid Therapy for Eosinophilic Esophagitis10.1016/j.cgh.2016.09.013 ↗
87. Mast Cell Production and Response to IL-4 and IL-1310.1016/j.cyto.2015.05.019 ↗
88. The Role of Biologics in Pediatric Food Allergy and Eosinophilic Gastrointestinal Disorders10.1016/j.jaci.2023.01.007 ↗
89. Dupilumab in Adults and Adolescents with Eosinophilic Esophagitis10.1056/NEJMoa2205982 ↗
90. Dupilumab: First Global Approval10.1007/s40265-017-0768-3 ↗
91. Burchett, J.R., Dailey, J.M., Kee, S.A., Pryor, D.T., Kotha, A., Kankaria, R.A., Straus, D.B., and Ryan, J.J. (2022). Targeting Mast Cells in Allergic Disease: Current Therapies and Drug Repurposing. Cells, 11.10.3390/cells11193031 ↗
92. Anti-IgE for the Treatment of Chronic Urticaria10.2147/ITT.S261416 ↗
93. Efficacy and Safety of Treatment with Omalizumab for Chronic Spontaneous Urticaria: A Systematic Review for the EAACI Biologicals Guidelines10.1111/all.14547 ↗
94. Immunotherapy and Biologics in the Management of IgE-mediated Food Allergy: Systematic Review and Meta-analyses of Efficacy and Safety10.1111/all.16129 ↗
95. Omalizumab in IgE-Mediated Food Allergy: A Systematic Review and Meta-Analysis10.1016/j.jaip.2022.11.036 ↗
96. Omalizumab for the Treatment of Multiple Food Allergies10.1056/NEJMoa2312382 ↗
97. A Practical Guide for Implementing Omalizumab Therapy for Food Allergy10.1016/j.jaci.2024.03.019 ↗
98. Eosinophilic Esophagitis in Adults Is Associated with IgG4 and Not Mediated by IgE10.1053/j.gastro.2014.05.036 ↗
99. Efficacy of Epicutaneous Immunotherapy in Children with Milk-Induced Eosinophilic Esophagitis10.1016/j.cgh.2019.05.014 ↗
100. Sustained Milk Consumption after 2 Years Post–Milk Epicutaneous Immunotherapy for Eosinophilic Esophagitis10.1111/all.14659 ↗